Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Emis Group Plc    EMIS   GB00B61D1Y04

Delayed Quote. Delayed  - 07/28 04:28:51 pm
1032 GBp   +0.78%
07/14 EMIS : Trading Broadly In Line And Full Year Expectations Unchanged
06/15 EMIS : Notification of Transactions of Directors
06/07 EMIS : Streets ahead in innovation
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Emis Group Plc : Smarter software to make GP prescribing safer

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/05/2012 | 07:41am CEST
Friday, 4 May 2012

Smarter software to make GP prescribing safer

A call from the General Medical Council (GMC) for smarter software to help GPs reduce prescribing errors has highlighted EMIS's position as an industry leader in decision support technology.

Many of the issues highlighted in the GMC-commissioned study are already covered by the EMIS Web integrated care system - including sophisticated prescribing alerts that don't overload the GP and direct electronic links with pharmacists, closing the prescribing loop.

GMC chair Professor Peter Rubin said GPs needed to invest in better technology following a GMC-commissioned study that revealed mistakes or omissions in one in 20 prescriptions. The GMC also called for GPs and pharmacists to work together more closely to reduce the risk of errors.

Complex decisions

Dr Shaun O'Hanlon, clinical and development director at EMIS said: "This important study has revealed just how complex prescribing decisions are, and as a former GP, I know that there are times when we need to balance one risk against another - this is often not evident when reviewing the prescription in isolation.

"However, the good news is that the smart software called for by the GMC is already being implemented - an increasing number of GPs and pharmacists using EMIS Web, our integrated record system, have the very latest tools to make prescribing safer.

Avoid 'alert fatigue'

"EMIS Web includes advanced decision support for prescribing, which flags up key drug safety alerts that make GPs stop and think, and even justify their decision, circumventing 'alert fatigue'.

"It also allows GPs to monitor and manage patients on drugs with a low therapeutic index such as Warfarin more safely. Our medication management tool informs GPs when the patient they are seeing or prescribing for is overdue for an INR check - the commonest serious issue mentioned in the report. Integration in EMIS Web of SMS alerting to the patient when monitoring is overdue is another way of improving safety - and involving patients in their own care." 

Linking GPs and pharmacists

He added: "Close links between GPs and local community pharmacists are of course vital to improve prescribing, and the Medicines Manager tool, developed jointly by EMIS and Rx Systems, allows them to communicate with each other electronically about patients' repeat medication and exchange information directly.

"GPs and community pharmacies are already collaborating when making complex prescribing decisions and are realising the benefits in terms of patient safety, compliance and improved care."

Media enquiries: Contact Libby Howard or Ruth Devlin, Judge & Howard,
tel: 0161 212 1611, email . Out-of-hours enquiries to
Libby Howard on 07879 446277.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EMIS GROUP PLC
07/14 EMIS : Trading Broadly In Line And Full Year Expectations Unchanged
06/15 EMIS : Notification of Transactions of Directors
06/07 EMIS : Streets ahead in innovation
06/01 EMIS : Exercise Of Share Options
05/16 EMIS : Notification of Transactions of Directors
04/26 EMIS : Trading In Line In 2016 With New Contracts Won Across Business
04/04 EMIS : Care fights diabetic sight loss
03/31 EMIS : Health puts GP record-sharing in patients’ hands
03/31 EMIS : QResearch data reveals risks of clinical outcomes for diabetes drugs with..
03/31 EMIS GROUP PLC : ex-dividend day for final dividend
More news
Sector news : Medical Software & Technology Services
07/25DJADRs End Lower; Philips Rises
07/25DJPHILIPS : Cost Savings, Strong Sales Boost Philips' Earnings
07/25DJPHILIPS : Profit Lifted by Health Technology Business
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
More sector news : Medical Software & Technology Services
News from SeekingAlpha
2015 NOVO-NORDISK'S ORAL GLP-1 DIABETES T : An Update
Advertisement
Financials ( GBP)
Sales 2016 168 M
EBIT 2016 35,8 M
Net income 2016 25,5 M
Finance 2016 0,10 M
Yield 2016 2,23%
P/E ratio 2016 25,28
P/E ratio 2017 22,86
EV / Sales 2016 3,87x
EV / Sales 2017 3,68x
Capitalization 648 M
More Financials
Chart EMIS GROUP PLC
Duration : Period :
Emis Group Plc Technical Analysis Chart | EMIS | GB00B61D1Y04 | 4-Traders
Full-screen chart
Technical analysis trends EMIS GROUP PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 11,2  GBP
Spread / Average Target 9,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Christopher Michael Kennedy Spencer Chief Executive Officer & Executive Director
Michael Kevin O'Leary Non-Executive Chairman
Peter Southby Chief Financial Officer & Executive Director
Shaun O’Hanlon Chief Medical Officer
Phil Webb Chief Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EMIS GROUP PLC-10.02%855
VEEVA SYSTEMS INC29.12%5 020
ALLSCRIPTS HEALTHCARE ..-8.13%2 643
PRESS GANEY HOLDINGS I..26.50%2 110
HEALTHEQUITY INC18.47%1 725
B-SOFT CO LTD--.--%1 407
More Results